Analysts are on the Bearish side about IQVIA HOLDINGS INC COM USD0.01 (NYSE:Q) this week.

April 7, 2018 - By Dolores Ford

Investors sentiment decreased to 0 in 2017 Q4. Its down 1.53, from 1.53 in 2017Q3. It fall, as 365 investors sold IQVIA HOLDINGS INC COM USD0.01 shares while 0 reduced holdings. 1 funds opened positions while 0 raised stakes. 50,840 shares or 99.97% less from 197.84 million shares in 2017Q3 were reported.
Massmutual Tru Fsb Adv owns 0.38% invested in IQVIA HOLDINGS INC COM USD0.01 (NYSE:Q) for 36,161 shares. Oregon Pub Employees Retirement Fund stated it has 14,679 shares.

IQVIA HOLDINGS INC COM USD0.01 (NYSE:Q) Ratings Coverage

Among 9 analysts covering Quintiles Transnational (NYSE:Q), 3 have Buy rating, 0 Sell and 6 Hold. Therefore 33% are positive. Quintiles Transnational has $125.0 highest and $92.0 lowest target. $108’s average target is 4.37% above currents $103.48 stock price. Quintiles Transnational had 13 analyst reports since October 9, 2017 according to SRatingsIntel. The rating was maintained by Stifel Nicolaus with “Hold” on Thursday, October 26. The rating was maintained by Jefferies with “Hold” on Friday, October 27. The firm has “Hold” rating by Robert W. Baird given on Thursday, October 26. On Monday, October 30 the stock rating was maintained by Jefferies with “Hold”. Credit Suisse maintained IQVIA HOLDINGS INC COM USD0.01 (NYSE:Q) on Monday, October 16 with “Buy” rating. On Thursday, November 9 the stock rating was downgraded by Mizuho to “Neutral”. Mizuho maintained the shares of Q in report on Thursday, October 26 with “Buy” rating. Robert W. Baird maintained the shares of Q in report on Monday, October 9 with “Hold” rating. The stock of IQVIA HOLDINGS INC COM USD0.01 (NYSE:Q) has “Sector Weight” rating given on Monday, November 13 by KeyBanc Capital Markets. On Tuesday, October 31 the stock rating was maintained by Credit Suisse with “Buy”. Below is a list of IQVIA HOLDINGS INC COM USD0.01 (NYSE:Q) latest ratings and price target changes.

13/11/2017 Broker: KeyBanc Capital Markets Old Rating: Overweight New Rating: Sector Weight Downgrade
09/11/2017 Broker: Morgan Stanley Rating: Overweight Old Target: $96 New Target: $121 Maintain
09/11/2017 Broker: Mizuho Old Rating: Buy New Rating: Neutral Old Target: $90 Downgrade
31/10/2017 Broker: Credit Suisse Rating: Buy New Target: $125.0 Maintain
30/10/2017 Broker: Jefferies Rating: Hold Old Target: $107 New Target: $110 Maintain
27/10/2017 Broker: Jefferies Rating: Hold New Target: $110.0 Maintain
27/10/2017 Broker: Barclays Capital Rating: Overweight Old Target: $100 New Target: $120 Maintain
26/10/2017 Broker: Mizuho Rating: Buy New Target: $100.0 Maintain
26/10/2017 Broker: Robert W. Baird Rating: Hold New Target: $105.0 Maintain
26/10/2017 Broker: Piper Jaffray Rating: Hold New Target: $101.0 Maintain

The stock increased 0.55% or $0.57 during the last trading session, reaching $103.48. About 1.30 million shares traded or Infinity% up from the average. IQVIA HOLDINGS INC COM USD0.01 (NYSE:Q) has 0.00% since April 7, 2017 and is . It has underperformed by 11.55% the S&P500.

Quintiles IMS Holdings, Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. The company has market cap of $. It operates through three divisions: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. It currently has negative earnings. The Commercial Solutions segment offers country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order to life science companies, and investment and financial sectors that deal with life science companies; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level to pharmaceutical sales organizations.

IQVIA HOLDINGS INC COM USD0.01 (NYSE:Q) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: